(Q67976198)

English

Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant

scientific article published on 01 October 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference

ChEBI release 2020-05-28

Streptomyces galilaeus

1 reference

6-Deoxy-D-788-7

1 reference

1-Hydroxy-D778-6

1 reference

1-Hydroxy-D-788-11

1 reference

1-Hydroxy-D-788-7

1 reference

author name string

A. Yoshimoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1473988

30 September 2022

O. Johdo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1473988

30 September 2022

H. Tone

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1473988

30 September 2022

R. Okamoto

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1473988

30 September 2022

H. Naganawa

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1473988

30 September 2022

T. Sawa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1473988

30 September 2022

T. Takeuchi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1473988

30 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1473988

30 September 2022

publication date

1992

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/45/10/45_10_1609/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.45.1609?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

45

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1609-1617

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.45.1609?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Antitumor anthracycline antibiotics, aclacinomycin A and analogues. II. Structural determination

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.801

Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.45.1255

Biosynthesis of daunomycinone from aklavinone and epsilon-rhodomycinone

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

New anthracycline antibiotics obtained by microbial glycosidation of beta-isorhodomycinone and alpha 2-rhodomycinone

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.39.902

Trisarubicinol, new antitumor anthracycline antibiotic

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.34.1492

New anthracycline antibiotic, 2-hydroxyaclacinomycin A

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.34.916

Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.1130

Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.1155

Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1609

Identifiers

10.7164/ANTIBIOTICS.45.1609

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1473988%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67976198&oldid=2127974290"